Vmbook Online ordering

Icons

**Company Information**

**Name:** ICON plc

**Symbol:** IONS (NYSE)

**Industry:** Healthcare Technology

**Business Overview**

ICON is a global provider of clinical research services to the pharmaceutical, biotechnology, and medical device industries. The company offers a range of services, including:

* Clinical trial design and management

* Data collection and analysis

* Regulatory compliance

* Patient recruitment and retention

**Financial Performance**

**Earnings:**

* Revenue: $3.8 billion (2022)

* Net income: $425 million (2022)

* Earnings per share (EPS): $2.54 (2022)

**Growth:**

* Revenue growth: 12% (2022)

* Net income growth: 15% (2022)

* EPS growth: 14% (2022)

**Key Metrics:**

* Backlog: $14.5 billion (2022)

* Number of employees: 18,000+

* Global presence: Over 100 countries

**Stock Performance**

* Stock price: $150 (as of March 8, 2023)

* Market capitalization: $13.5 billion

* 52-week range: $115 - $175

**Outlook**

ICON is well-positioned for continued growth in the clinical research market. The company's strong backlog, global presence, and expertise in complex trials provide a solid foundation for future success.

**Analysts' Recommendations**

* Buy: 10

* Hold: 2

* Sell: 0

**Risks**

* Competition from other clinical research organizations

* Regulatory changes

* Currency fluctuations

* Dependence on large pharmaceutical clients